Stoke Therapeutics, Inc. (STOK)
36.17
-0.06
(-0.17%)
USD |
NASDAQ |
Feb 24, 11:42
Stoke Therapeutics EPS Diluted from Accounting Change (Quarterly)
EPS Diluted from Accounting Change (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted from Accounting Change (Quarterly) Benchmarks
| Biogen, Inc. | -- |
| Insmed, Inc. | -- |
| Pfizer Inc. | -- |
| Mirum Pharmaceuticals, Inc. | -- |
| Moderna, Inc. | -- |